![](/img/cover-not-exists.png)
Discontinuation due to immune‐related adverse events is a possible predictive factor for immune checkpoint inhibitors in patients with non‐small cell lung cancer
Komiya, Kazutoshi, Nakamura, Tomomi, Abe, Tomonori, Ogusu, Shinsuke, Nakashima, Chiho, Takahashi, Koichiro, Kimura, Shinya, Sueoka‐Aragane, NaokoJournal:
Thoracic Cancer
DOI:
10.1111/1759-7714.13149
Date:
July, 2019
File:
PDF, 287 KB
2019